BiomX Inc. (PHGE)
About BiomX Inc.
BiomX Inc is a company focused on acquiring and further developing technologies that identify, track, and counter physical threats across defense, security, critical infrastructure, and first-response sectors. The Company's portfolio is built around the growing need for earlier and more accurate threat detection, particularly as UAVs and other autonomous systems play a larger role in defense and homeland security.
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Net income
- -$36.2M
- Total assets
- $5.8M
- Market cap
- $2.0M
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $2.0M
- Shares outstanding
- 1.1M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Mar 13, 2019
BiomX Inc. (PHGE) Stock Price
- Reported a net loss of $36.2M.
- Trading 85% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review BiomX Inc..
Write a review
News about BiomX Inc.
News & sentiment via Polygon.io
BiomX Inc.: frequently asked questions
Is BiomX Inc. an American company?
BiomX Inc. is a US-based company headquartered in Dover, Delaware, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is BiomX Inc. headquartered?
BiomX Inc. is headquartered in Dover, Delaware, United States.
Is BiomX Inc. publicly traded?
Yes — BiomX Inc. is a publicly traded company. Its stock trades under the ticker symbol PHGE on the NYSE.
What does BiomX Inc. do?
BiomX Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
